New online therapy aims to ease brain tumor Patients' worst fears

NCT ID NCT06989086

Recruiting now Symptom relief Sponsor: Virginia Commonwealth University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing a new virtual therapy program called FearLess, designed to help people with primary malignant brain tumors and their caregivers cope with the intense fear that their cancer might come back. The program involves 8 weekly one-on-one video sessions with a therapist. Researchers want to see if this approach is practical and acceptable to participants, and to fine-tune the study design for a future larger trial. About 112 patients and caregivers will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: FearLess psychological intervention (virtual therapy sessions)
What this could lead to: If it works, this could provide a new, accessible way to help brain tumor patients and their caregivers manage fear and anxiety about cancer returning.
What could go wrong: This is an early feasibility study with no control group comparison yet, so it cannot prove the therapy reduces fear. The small size and short follow-up may limit how well the results apply to others.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTROCYTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

astrocytoma (excluding glioblastoma) brain cancer glioblastoma oligodendroglioma primary brain neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTROCYTOMA CAREGIVER GLIOBLASTOMA (GBM) OLIGODENDROGLIOMA PRIMARY MALIGNANT BRAIN TUMOR

Contacts and locations

Locations

Virginia Commonwealth University
RECRUITING

Richmond, Virginia, 23298, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.